Tonino, R.P., Meunier, P.J., Emkey, R., Rodriguez-Portales, J.A., Menkes, C., Wasnich, R.D., et al. (2000) Skeletal Benefits of Alendronate: 7-Year Treatment of Postmenopausal Osteoporotic Women. The Journal of Clinical Endocrinology & Metabolism, 85, 3109-3115.
https://doi.org/10.1210/jc.85.9.3109

has been cited by the following article:

• TITLE: Bisphosphonates Zoledronate and Alendronate for the Management of Postmenopausal Osteoporosis

  AUTHORS: IsraaIsraa Ahmed Radwan, Nahed Sedky Korany, Bassant Adel Ezzat

  KEYWORDS: Bisphosphonates, Alendronate, Zoledronate, Postmenopausal Osteoporosis

  JOURNAL NAME: Case Reports in Clinical Medicine, Vol.7 No.5, May 10, 2018

  ABSTRACT: Bisphosphonates are among the most frequently used antiresorptive drugs for the management of postmenopausal osteoporosis. We review here two of the commonly used bisphosphonates zoledronate and alendronate.